Factory 99% Sulfadoxine Powder CAS 2447-57-6 Chemical Intermediate Sulfadoxine

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A715
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Sulfadoxine
• CAS: 2447-57-6
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 1g
• Function: Chemical Intermediate
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

 

Product Name	Sulfadoxine
Appearance	White Powder
CAS NO.	2447-57-6
MF	C12H14N4O4S
Storage	Keep in a cool, dry, dark location

 

Sulfadoxine is a synthetic chemical compound characterized by its sulfonamide structure. It acts as an antibacterial and antiprotozoal agent by inhibiting the synthesis of dihydrofolate, an essential component in the folate metabolism pathway of bacteria and certain parasites.

 

1. Antimalarial Therapy: Sulfadoxine is commonly used in combination with pyrimethamine (as the drug pair known as SP) for the treatment and prophylaxis of malaria, particularly in areas where Plasmodium falciparum is resistant to chloroquine.
2. Veterinary Medicine: It is also employed in veterinary practice for treating various animal infections caused by susceptible bacteria and protozoa.
3. Research and Development: Sulfadoxine serves as a research tool in pharmacological studies, aiding in the understanding of folate metabolism and the development of new antimicrobial agents.

1. Bacterial Inhibition: By interfering with dihydrofolate reductase, sulfadoxine disrupts the bacterial folate cycle, leading to the inhibition of bacterial growth and replication.
2. Protozoal Eradication: In parasites such as Plasmodium, it similarly blocks folate synthesis, essential for their survival and multiplication within the host.
3. Synergistic Effects: When combined with other drugs like pyrimethamine, sulfadoxine enhances the overall effectiveness of the treatment regimen by targeting different stages of the parasite's life cycle or by inhibiting alternative metabolic pathways.